These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15322634)

  • 1. Oral Candida flora from Brazilian human immunodeficiency virus-infected patients in the highly active antiretroviral therapy era.
    Melo NR; Taguchi H; Jorge J; Pedro RJ; Almeida OP; Fukushima K; Nishimura K; Miyaji M
    Mem Inst Oswaldo Cruz; 2004 Jun; 99(4):425-31. PubMed ID: 15322634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Species distribution and antifungal susceptibility profile of oral candida isolates from HIV-infected patients in the antiretroviral therapy era.
    Costa CR; de Lemos JA; Passos XS; de Araújo CR; Cohen AJ; Souza LK; Silva Mdo R
    Mycopathologia; 2006 Jul; 162(1):45-50. PubMed ID: 16830191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral candidiasis of HIV-infected children undergoing sequential HIV therapies.
    Melo NR; Taguchi H; Culhari VP; Kamei K; Mikami Y; Smith SN; Vilela MS
    Med Mycol; 2009 Mar; 47(2):149-56. PubMed ID: 18651304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China.
    Jiang L; Yong X; Li R; Peng Y; Liu W; Qin Q; Zhang L; Liu Z; Liang H; Tao R
    J Oral Pathol Med; 2014 Oct; 43(9):696-703. PubMed ID: 24931443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
    Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
    AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral Candida isolates among HIV-infected subjects in Nigeria.
    Nweze EI; Ogbonnaya UL
    J Microbiol Immunol Infect; 2011 Jun; 44(3):172-7. PubMed ID: 21524610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral colonization by yeasts in HIV-positive patients in Brazil.
    Junqueira JC; Vilela SF; Rossoni RD; Barbosa JO; Costa AC; Rasteiro VM; Suleiman JM; Jorge AO
    Rev Inst Med Trop Sao Paulo; 2012; 54(1):17-24. PubMed ID: 22370749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point prevalence, microbiology and antifungal susceptibility patterns of oral Candida isolates colonizing or infecting Mexican HIV/AIDS patients and healthy persons.
    Sánchez-Vargas LO; Ortiz-López NG; Villar M; Moragues MD; Aguirre JM; Cashat-Cruz M; Lopez-Ribot JL; Gaitán-Cepeda LA; Quindós G
    Rev Iberoam Micol; 2005 Jun; 22(2):83-92. PubMed ID: 16107165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymptomatic oral yeast carriage and antifungal susceptibility profile of HIV-infected patients in Kunming, Yunnan Province of China.
    Li YY; Chen WY; Li X; Li HB; Li HQ; Wang L; He L; Yang XP; Wang XC; Huang YL; Yao YG
    BMC Infect Dis; 2013 Jan; 13():46. PubMed ID: 23356471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent oral candidosis by non-albicans Candida strains including Candida glabrata in a human immunodeficiency virus-infected patient observed over a period of 6 years.
    Hoegl L; Thoma-Greber E; Röcken M; Korting HC
    Mycoses; 1998; 41(7-8):335-8. PubMed ID: 9861840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing and the Clinical Laboratory Standards Institute BMD method for non-Candida albicans and non-C. tropicalis bloodstream isolates from eleven tertiary hospitals in São Paulo state, Brazil.
    Purisco SU; Martins MA; Szeszs MW; Castro e Silva DM; Pukinskas SR; Bonfietti LX; Baez AA; Melhem MS
    FEMS Yeast Res; 2012 Dec; 12(8):890-6. PubMed ID: 22883021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
    Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
    Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection.
    Tumbarello M; Caldarola G; Tacconelli E; Morace G; Posteraro B; Cauda R; Ortona L
    J Antimicrob Chemother; 1996 Oct; 38(4):691-9. PubMed ID: 8937963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predisposing factors for oropharyngeal colonization of yeasts in human immunodeficiency virus-infected patients: a prospective cross-sectional study.
    Lin JN; Lin CC; Lai CH; Yang YL; Chen HT; Weng HC; Hsieh LY; Kuo YC; Lauderdale TL; Tseng FC; Lin HH; Lo HJ
    J Microbiol Immunol Infect; 2013 Apr; 46(2):129-35. PubMed ID: 22921200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence, risk factors and antifungal sensitivity pattern of oral candidiasis in HIV/AIDS patients in Kumba District Hospital, South West Region, Cameroon.
    Ambe NF; Longdoh NA; Tebid P; Bobga TP; Nkfusai CN; Ngwa SB; Nsai FS; Cumber SN
    Pan Afr Med J; 2020; 36():23. PubMed ID: 32774600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility of oral Candida to seven antifungal agents.
    Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
    Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Candida colonization and its relation with predisposing factors in HIV-infected children and their uninfected siblings in Brazil: the era of highly active antiretroviral therapy.
    Cerqueira DF; Portela MB; Pomarico L; de Araújo Soares RM; de Souza IP; Castro GF
    J Oral Pathol Med; 2010 Feb; 39(2):188-94. PubMed ID: 20040023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and microbiological assessment of patients with a long-term diagnosis of human immunodeficiency virus infection and Candida oral colonization.
    Delgado AC; de Jesus Pedro R; Aoki FH; Resende MR; Trabasso P; Colombo AL; de Oliveira MS; Mikami Y; Moretti ML
    Clin Microbiol Infect; 2009 Apr; 15(4):364-71. PubMed ID: 19431223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
    Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.